PLAINSBORO, N.J., Feb. 19, 2003 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 AM EST on Thursday, February 27 to discuss financial results for the fourth quarter and year ended December 31, 2002 and to update forward-looking financial guidance. Financial results for the fourth quarter and full year 2002 will be announced via a news release issued before the market opens on February 27.
The upcoming conference call, which will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, is open to all listeners and will be followed by a question and answer session. Additional forward-looking information may be discussed in the question and answer session following the call.
Access to the live call is available by dialing (973) 935-2100 or through a listen-only webcast via a link provided on the home page of Integra's website at www.Integra-LS.com. A replay of the conference call will be accessible starting one hour following the live event. Access to the replay is available through March 13 by dialing 973-341-3080 or through the webcast accessible on our home page.
Mr. Essig's presentation will provide an overview of the Company's operating divisions, a review of recent financial history, including financial results from the fourth quarter and year ended December 31, 2002, and the Company's overall business strategy.
Integra LifeSciences Holdings Corporation is a global, diversified medical device company that develops, manufactures, and markets medical devices, implants and biomaterials primarily for use in neurosurgery, orthopedics and soft tissue repair. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. The Company has its corporate headquarters in Plainsboro, New Jersey, with manufacturing and research facilities located throughout the world. The Company has approximately 790 permanent employees.
Statements made in the upcoming conference call may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted results. Forward-looking factors that may be discussed include, but are not limited to, expected future financial results, new product development, governmental approvals, market potential, expected sales and potential therapeutic applications of new products, and additional business acquisitions. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in the Business section of Integra's Annual Report on Form 10-K for the year ended December 31, 2001 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.